Agios Pharmaceuticals | AGIO - Umsatzerlöse

Aktienkurs
28.05
Täglich Wechseln
0 0%
Monatlich
-17.09%
Jährlich
-9.34%
Q2 Prognose
24.78




Der Umsatz Veränderung Datum
AbbVie USD 15B 1.62B 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amgen USD 9.9B 340M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 11.44B 1.78B 2025-12
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Daiichi Sankyo JPY 587B 28.89B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Exelixis USD 598.66M 860K 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Merck USD 16.29B 110M 2026-03
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Pfizer USD 17.58B 880M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12